Windows users who regularly use Microsoft Teams are being urged to be extra cautious as a new malicious attack is sweeping over PCs without their users knowledge. Since the Covid pandemic, many ...

Goldman Sachs launched its coverage of Exelixis (NASDAQ:EXEL) with a Buy recommendation and a $47 target, citing the potential of its lead candidate, zanzalintinib, in offsetting an upcoming patent ...

EXEL continues to grow cabozantinib revenues while advancing zanzalintinib, but recent trial updates have been mixed and market reaction muted. STELLAR-303 has produced a success for zanzalintinib, ...

Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Exelixis (EXEL) and argenex SE (ARGX). But which of these two companies is the best option for those ...

Former Los Angeles Lakers and Dallas Mavericks point guard Nick Van Exel played 13 seasons in the NBA, during which he became one of the quickest and most explosive scoring and passing guards in the ...

Cincinnati Bearcats fans were buzzing about tweets Monday from former UC greats Sean Kilpatrick and Nick Van Exel, both UC Athletics Hall of Famers. With a vacancy on the coaching staff left by Drew ...

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Exelixis (EXEL) or argenex SE (ARGX). But which of these two stocks presents investors with ...

Mr. Loukola currently serves as Senior Vice President, Wind at Exel Composites. Over the past 11 years Mr. Loukola has held several senior leadership positions within Exel, including SVP & General ...

Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Exelixis (EXEL) and Techne (TECH). But which of these two stocks is more attractive to value ...

Shares of oncology company Exelixis, Inc. (EXEL) gaining on rising revenue, pipeline progress. EXEL designs advanced medicines and regimens to battle cancer. Its product portfolio focuses on an ...